Readers warn that the Trump administration’s defunding of medical research will cost lives. Also: President Trump’s remarks ...
In December 2023, through the development efforts of CRISPR Therapeutics and Vertex Pharmaceuticals, their decades-long ...
Prescription totals for Attruby, which is locked in a closely watched commercial battle with Pfizer’s tafamidis, have more ...
Questioning a chatbot that has been trained on bestselling books from a particular decade can give researchers a measure of the social biases of that era ...
Research reports from Morningstar & Argus help you make better investment decisions. Leverage these to understand future stock performance and identify high performing investment ideas. You can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results